Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

302 Outcomes Related to Penile Prosthesis Reservoir Removal: A Multi-institutional Experience
Clavell-Hernández, Jonathan, Supak, Dylan N., Trost, Landon , Köhler, Tobias , Henry, G.D., Loeb, Aram, Cornell, Robert J., Wang, R., Wang, R.

Mayo Clinic

The Journal of Sexual Medicine | January 1, 2020 | Volume: 17 | Issue: Supplement_1 | Pages: S71-S72

10.1016/j.jsxm.2019.11.199 Get It

105 Impact of Antimicrobial Dipping Solutions on Post-Operative Infection Rates in Diabetic Patients Undergoing Primary Insertion of a Coloplast Titan Inflatable Penile Prosthesis
Osman, Mohamad M. , Andrianne, Robert, Guise, Amy, Hatzichristodoulou, Georgios , Henry, G.D., Hsieh, Tung‐Chin , Lentz, A.C., Munarriz, Ricardo , Osmonov, Daniar , Perito, Paul , Sadeghi‐Nejad, Hossein , Simhan, Jay , Wang, R., Yafi, Faysal A. , Collaborators, D., Broderick, Gregory A. , Burnett, Arthur L. “Bud” , Gross, Martin , Jenkins, Lawrence C. , Lentz, A.C., Park, S.

Mayo Clinic

The Journal of Sexual Medicine | January 1, 2020 | Volume: 17 | Issue: Supplement_1 | Pages: S25-S25

10.1016/j.jsxm.2019.11.051 Get It

106 Immediate Preoperative Blood Glucose and Hemoglobin A1c Levels are not Predictive of Post-Operative Infections in Diabetic Men Undergoing Penile Prosthesis Placement
Osman, Mahdi, Andrianne, Robert, Burnett, A.L., Guise, Amy, Hatzichristodoulou, Georgios , Henry, G.D., Hsieh, Tung‐Chin , Lentz, A.C., Munarriz, Ricardo , Osmonov, Daniar , Park, S., Perito, Paul , Sadeghi‐Nejad, Hossein , Simhan, Jay , Wang, R., Yafi, Faysal A. , Collaborators, D., Broderick, Gregory A. , Gross, Martin , Henry, G.D., Jenkins, Lawrence C. , Lentz, A.C., Park, S Hun, Wang, R.

Mayo Clinic

The Journal of Sexual Medicine | January 1, 2020 | Volume: 17 | Issue: Supplement_1 | Pages: S25-S26

10.1016/j.jsxm.2019.11.052 Get It

028 Adherence to the AUA Penile Prosthesis Antibiotic Prophylaxis Guidelines in Diabetic Patients is Associated with Significantly Higher Risks of Device Infection
Towe, Maxwell , Andrianne, Robert, Guise, Amy, Hatzichristodoulou, Georgios , Henry, G.D., Hsieh, Tang‐Hsu , Lentz, A.C., Munarriz, Ricardo , Osmonov, Daniar , Park, S., Perito, Paul , Sadeghi‐Nejad, Hossein , Simhan, Jay , Wang, R., Yafi, Faysal A. , Collaborators, D., Broderick, Gregory A. , Burnett, Arthur L. “Bud” , Gross, Martin , Henry, G.D., Jenkins, Lawrence C. , Lentz, A.C., Park, S Hun

Mayo Clinic

The Journal of Sexual Medicine | January 1, 2020 | Volume: 17 | Issue: Supplement_1 | Pages: S15-S15

10.1016/j.jsxm.2019.11.030 Get It

Photodynamic Therapy for Gastrointestinal Cancer
Yano, Tomonori , Wang, Kenneth K.

Mayo Clinic

Photochemistry and Photobiology | December 30, 2019 | Volume: 96 | Issue: 3 | Pages: 517-523

10.1111/php.13206 | PMID 31886891 Get It

AbstractThe clinical application of photodynamic therapy (PDT) for gastrointestinal (GI) neoplastic lesions has been developed with appreciation for the great efforts and kind support of Dr. Tom Dougherty and his followers’ contributions. There are several published studies on clinical PDT in the field of GI oncology. Esophageal cancer was one of the first clinical indications for PDT that was approved as an endoscopic procedure in both the United States and Japan. PDT was initially used as a palliative local treatment for patients with obstructive esophageal cancer. PDT is also indicated for eradicative therapy for dysplastic Barret’s esophagus, which is the precursor state of esophageal adenocarcinoma, with the support of level one evidence. In Japan, PDT was approved as a curative treatment for superficial esophageal carcinoma lesions, which are difficult to treat with endoscopic resection. Further, PDT using second‐generation photosensitizers is approved for early local failure after radiotherapy, for which treatment with other modalities is difficult. PDT has also been assessed in other GI cancers, including gastric cancer, biliary cancer and pancreatic cancer. In this review, we overview the history and state of PDT for GI cancer.
Revisiting Criteria for Psychosis in Alzheimer’s Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research
Ismail, Zahinoor , Youakim, James M. , Kumar, Sanjeev , Núñez, Nicolás A. , Darby, R. Ryan , D’Antonio, Fabrizia , Lena, Carlo de , McGeown, William J. , Ravona, Ramit, Rasmussen, J , Bell, J. Simon , Wang, Huali , Bruneau, Marie‐Andrée , Agüera-Ortíz, Luis , Lyketsos, Constantine G. , Sano, Mary , Devanand, Davangere P. , Ballard, Clive , Nunez, Nicolas, Ballard, Clive , Fischer, Corinne Eleanor , Creese, Byron , Vita, Antonella Di , Panegyres, Peter K. , Lanctôt, Krista L. , Cummings, Jeffrey L. , Jeste, Dilip V. , Sweet, Robert A.

Mayo Clinic

Journal of Alzheimer’s Disease | December 27, 2019 | Volume: 73 | Issue: 3 | Pages: 1143-1156

10.3233/jad-190828 | PMID 31884469 Get It

Background: Psychotic symptoms are common in Alzheimer’s disease (AD) and related neurodegenerative disorders and are associated with more rapid disease progression and increased mortality. It is unclear to what degree existing criteria are utilized in clinical research and practice. Objective: To establish research criteria for the diagnosis of psychosis in AD. Methods: The International Society to Advance Alzheimer’s Research and Treatment (ISTAART) Neuropsychiatric Symptoms (NPS) Professional Interest Area (PIA) psychosis subgroup reviewed existing criteria for psychosis in AD and related dementias. Through a series of in person and on-line meetings, a priority checklist was devised to capture features necessary for current research and clinical needs. PubMed, Medline and other relevant databases were searched for relevant criteria. Results: Consensus identified three sets of criteria suitable for review including those of Jeste and Finkel, Lyketsos, and the Diagnostic and Statistical Manual for Mental Disorders, 5th edition. It was concluded that existing criteria could be augmented by including a more specific differentiation between delusions and hallucinations, address overlap with related conditions (agitation in particular), adding the possibility of symptoms emerging in the preclinical and prodromal phases, and building on developing research in disease biomarkers. Conclusion: We propose criteria, developed to improve phenotypic classification of psychosis in AD, and advance the research agenda in the field to improve epidemiological, biomarker, and genetics research in the field. These criteria serve as a complement to the International Psychogeriatric Association criteria for psychosis in neurocognitive disorders.
Clinicopathologic, Immunohistochemical, and Molecular Characteristics of Ovarian Serous Carcinoma With Mixed Morphologic Features of High-grade and Low-grade Serous Carcinoma
Zarei, Shabnam , Jenkins, Sarah M. , Voss, Jesse S. , Kerr, Sarah E. , Bell, Debra A., Wang, Yan

Mayo Clinic

American Journal of Surgical Pathology | December 24, 2019 | Volume: 44 | Issue: 3 | Pages: 316-328

10.1097/pas.0000000000001419 | PMID 31876585 Get It

Despite the current classification of high-grade serous carcinoma (HGSCA) and low-grade serous carcinoma (LGSCA) as mutually exclusive diseases based on morphology and molecular pathogenesis, cases with mixed morphologic features of HGSCA and LGSCA have been reported. Herein we assess the clinicopathologic, immunohistochemical (IHC), and molecular genetic characteristics of a group of these cases, which we termed indeterminate grade serous carcinoma (IGSCA) in comparison with groups of HGSCA and LGSCA. Using the World Health Organization (WHO) classification criteria, we selected 27 LGSCA and 19 IGSCA for detailed morphologic study. Thirteen classic HGSCA, 19 classic LGSCA, and 19 IGSCA were selected for p53 and BRAF V600E IHC and molecular genetic testing by next-generation sequencing. IGSCA showed the architectural patterns of invasion of LGSCA, but with higher grade nuclear features focally and a mitotic index intermediate between LGSCA and HGSCA. Few cases in the IGSCA group showed mutant TP53 by IHC or sequencing (4/18, 22.2%), 1 case had mutant BRAF non-V600E by sequencing, and 1 had an NRAS mutation. When present, the mutations were identical in the low-grade and high-grade areas. The IGSCA group had a long-term survival similar to the classic HGSCA group. IGSCA with mixed morphologic features of HGSCA and LGSCA is a rare and potentially clinically aggressive variant of serous carcinoma. Their distinct morphologic, but heterogenous molecular features, including low frequency of TP53 and BRAF mutations suggest that these rare tumors may have a different pathogenesis pathway compared with classic HGSCA and classic LGSCA.
Symptom checkers versus doctors: A prospective, head‐to‐head comparison for cough
Berry, Andrew C. , Berry, Nicholas A. , Wang, Bin , Mulekar, Madhuri S. , Melvin, Anne, Battiola, Richard J., Bulacan, Frederick K., Berry, Bruce B.

Mayo Clinic

The Clinical Respiratory Journal | December 20, 2019 | Volume: 14 | Issue: 4 | Pages: 413-415

10.1111/crj.13135 | PMID 31860762 Get It

Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients
Whitmire, Paula , Rickertsen, Cassandra , Lorence, Julia, León, Gustavo De , Bayless, Spencer, Clark-Swanson, Kamala , Corpuz, Christina, Angeles, Christine Paula Lewis-de los, Vora, Sujay A., Mrugała, Maciej M. , Hu, Leland , Porter, Alyx B. , Kumthekar, Priya , Johnston, Sandra K. , Egan, Kathleen M. , Canoll, Peter , Swanson, Kristin R. , Swanson, Kristin R , Hawkins‐Daarud, Andrea , Carrasco, Eduardo, Leon, Gustavo De, Curtin, Lee , Peeri, Noah Charles , Bendok, Bernard R. , Gonzalez‐Cuyar, Luis F. , Wang, Lei G. , Gatenby, Robert A. , Rubin, Joshua B

Mayo Clinic

No container title available | December 19, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.10177/v3 Get It

Abstract Background : Sex is recognized as a significant determinant of outcome among glioblastoma patients, but the relative prognostic importance of glioblastoma features has not been thoroughly explored for sex differences. Methods : Combining multi-modal MR images, biomathematical models, and patient clinical information, this investigation assesses which pretreatment variables have a sex-specific impact on the survival of glioblastoma patients (299 males and 195 females). Results : Among males, tumor (T1Gd) radius was a predictor of overall survival (HR=1.027, p=0.044). Among females, higher tumor cell net invasion rate was a significant detriment to overall survival (HR=1.011, p<0.001). Female extreme survivors had significantly smaller tumors (T1Gd) (p=0.010 t-test), but tumor size was not correlated with female overall survival (p=0.955 CPH). Both male and female extreme survivors had significantly lower tumor cell net proliferation rates than other patients (M p=0.004, F p=0.001, t-test). Conclusion : Despite similar distributions of the MR imaging parameters between males and females, there was a sex-specific difference in how these parameters related to outcomes.